 |
| Lori Moore |
Germany's Bayer has brought on Lori Moore as VP & head of pharmaceutical communications in the US.
Moore moves to Bayer from Deloitte, where she most recently served as managing director, leading the company’s efforts to transform its internal communications.
Prior to joining Deloitte, she held communications leadership positions at Novo Nordisk and Sanofi.
At Bayer, Moore will be responsible for developing and executing external and internal communication strategies for the company’s pharmaceutical portfolio in the U.S., with a specific emphasis on cardiology, oncology, women’s health, hematology and radiology.
“Her impressive knowledge and expertise will help us advance our communications about the company’s pharmaceutical business here in this country,” said Ray Kerins, Bayer senior VP of corporate affairs.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
